SL Science Holding Ltd
SL Science Holding Ltd
Your view on SLBT
Overview
What the company does, where it operates, and who runs it.
About SL Science Holding Ltd
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- William Wang
- Headquarters
- 1412 Broadway, New York, NY, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- William Wang
- Headquarters
- 1412 Broadway, New York, NY, US
Horizon Space Acquisition II Corp. aims to achieve strategic business combinations with other companies. This objective can be fulfilled through various transactional structures, including mergers, exchanges of shares, acquisitions of assets, direct purchases of stock, recapitalizations, or other forms of corporate reorganization.
The firm was founded in 2023 and maintains its headquarters in New York, New York.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for SL Science Holding Ltd from FRC's valuation model, read against the market price. SLBT last traded at $0.66; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for SL Science Holding Ltd. Starting points for SL Science Holding Ltd: beta 0.09 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for SL Science Holding Ltd. SL Science Holding Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for SL Science Holding Ltd. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for SL Science Holding Ltd. SL Science Holding Ltd has reported as a listed company since 2025. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- ACRSAclaris Therapeutics, Inc.Biotechnology$555M
- MDWDMediWound Ltd.Biotechnology$176M
- OCSOculis Holding AGBiotechnology$456M
- SLGLSol-Gel Technologies Ltd.Biotechnology$175M
- TTRXTurn Therapeutics Inc.Biotechnology$272M
More Biotechnology companies
- EWTXEdgewise Therapeutics, Inc.NASDAQ$4.5B
- EXELExelixis, Inc.NASDAQ$17.2B
- EXOZeXoZymes, Inc.NASDAQ$32M
- EYPTEyePoint Pharmaceuticals, Inc.NASDAQ$31M
- EZZ.AXEZZ Life Science Holdings LimitedASX
- FAMDFFutura Medical plcOTC$6M
- FATEFate Therapeutics, Inc.NASDAQ$122M
- FBIOFortress Biotech, Inc.NASDAQ$63M
- FBIOPFortress Biotech, Inc.NASDAQ$57M
- FBLGFibroBiologics, Inc. Common StockNASDAQ$6M
- FDMT4D Molecular Therapeutics, Inc.NASDAQ$578M
- FENCFennec Pharmaceuticals Inc.NASDAQ$471M
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by SL Science Holding Ltd executives and directors. Shares of SL Science Holding Ltd have traded between $2.54 and $14.50 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for SL Science Holding Ltd. Coverage tracks SL Science Holding Ltd within Biotechnology (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of SL Science Holding Ltd.